Abstract: Fermentation media containing an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and at least one exogenous added ingredient that comprises a substrate for microbial growth are provided. Methods of making a fermentation medium comprising an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and methods for obtaining a fermentation product are also provided. The present invention is further directed to fermentation broths obtained by the media and methods. The present invention is also directed to feed additives produced from fermentation broths obtained by the methods.
Abstract: Fermentation media containing an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and at least one exogenous added ingredient that comprises a substrate for microbial growth are provided. Methods of making a fermentation medium comprising an isoflavone-depleted soybean meal or isoflavone-depleted soybean meal product and methods for obtaining a fermentation product are also provided. The present invention is further directed to fermentation broths obtained by the media and methods. The present invention is also directed to feed additives produced from fermentation broths obtained by the methods.
Abstract: A process of increasing the cellular production of biologically active compounds is provided. The process is particularly useful for increasing antibiotic production by bacterial cells. The process includes the step of inhibiting the activity of methylmalonyl-CoA mutase.
Type:
Grant
Filed:
August 8, 2003
Date of Patent:
December 29, 2009
Assignee:
Fermalogic, Inc.
Inventors:
J. Mark Weber, Andrew R. Reeves, Igor A. Brikun, William Henry Cernota
Abstract: A process of increasing the cellular production of biologically active compounds is provided. The process is particularly useful for increasing antibiotic production by bacterial cells. The process includes the step of inhibiting the activity of methylmalonyl-CoA mutase.
Type:
Application
Filed:
August 8, 2003
Publication date:
October 19, 2006
Applicant:
Fermalogic, Inc.
Inventors:
J. Weber, Andrew Reeves, Igor Brikun, William Cernota
Abstract: The present invention relates to a method of improving the strain used for the production of erythromycin through the disruption of the melA gene.
Abstract: The present invention provides isolated and purified polypeptides that increase antibiotic production, polynucleotides that encode those polypeptides, expression vectors containing those polynucleotides, host cells transformed with those expression vectors, a process of making the polypeptides using those polynucleotides and vectors, and processes using those polypeptides and polynucleotides.
Type:
Grant
Filed:
May 7, 1997
Date of Patent:
November 2, 1999
Assignee:
FermaLogic, Inc.
Inventors:
J. Mark Weber, Paul E. Hessler, Peter E. Larsen, Minh B. Luu
Abstract: The present invention provides a process of preparing the isoflavone genistein. Genistein is prepared by fermenting the bacteria Saccharopolyspora erythraea in the presence of a soy-based substrate. A process of recovering genistein from a bacterial fermentation medium using alkaline, organic solvent extraction is also provided.
Type:
Grant
Filed:
August 7, 1995
Date of Patent:
September 10, 1996
Assignee:
FermaLogic, Inc.
Inventors:
J. Mark Weber, Andreas Constantinou, Paul E. Hessler